Innovaderm Research

Child with eczema
#Atopic dermatitis #Clinical trial #Clinical trial design #Innovaderm Research #Phase I trial #RAPT Therapeutics

Clinical data supports oral treatment for atopic dermatitis

A new drug for atopic dermatitis (AD) has demonstrated a positive clinical effect and improvements in various efficacy endpoints after four weeks of treatment. The Phase Ia/IIb study was designed to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and CCR4 surface receptor occupancy of zelnecirnon in eligible… Read More

#News